Design Therapeutics, Inc. (DSGN)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
DSGN Insider Trading Activity
DSGN Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $104,604 | 3 | 60 |
Sells | $3,487,078 | 2 | 40 |
Related Transactions
| Schmid John P. | director | 2 | $99,738 | 0 | $0 | $99,738 |
| Berger Heather A. | director | 1 | $4,866 | 0 | $0 | $4,866 |
| Prasad Deepa | director | 0 | $0 | 1 | $23,864 | $-23,864 |
| William Arsani | director | 0 | $0 | 1 | $3.46M | $-3.46M |
About Design Therapeutics, Inc.
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive …
Insider Activity of Design Therapeutics, Inc.
Over the last 12 months, insiders at Design Therapeutics, Inc. have bought $104,604 and sold $3.49M worth of Design Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Design Therapeutics, Inc. have bought $15.55M and sold $1.88M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $99,738. Berger Heather A. (director) — $4,866.
The last purchase of 17,809 shares for transaction amount of $66,606 was made by Schmid John P. (director) on 2024‑03‑25.
List of Insider Buy and Sell Transactions, Design Therapeutics, Inc.
| 2024-12-18 | Sale | Prasad Deepa | director | 3,806 0.0073% | $6.27 | $23,864 | -17.23% | |
| 2024-08-09 | Sale | William Arsani | director | 814,874 1.4426% | $4.25 | $3.46M | +23.11% | |
| 2024-03-25 | Schmid John P. | director | 17,809 0.0318% | $3.74 | $66,606 | +26.87% | ||
| 2024-03-25 | Berger Heather A. | director | 1,300 0.0023% | $3.74 | $4,866 | +26.87% | ||
| 2024-03-22 | Schmid John P. | director | 9,156 0.0156% | $3.62 | $33,133 | +24.74% | ||
| 2023-09-29 | LAPPE RODNEY W | director | 21,000 0.0373% | $2.35 | $49,287 | +41.10% | ||
| 2023-08-29 | William Arsani | director | 1.96M 3.6838% | $2.44 | $4.78M | +19.26% | ||
| 2023-08-29 | Prasad Deepa | director | 12,000 0.0213% | $2.31 | $27,670 | +19.26% | ||
| 2023-08-28 | William Arsani | director | 275,000 0.48% | $2.15 | $591,250 | +24.09% | ||
| 2022-12-20 | SR One Capital Fund I Aggregator LP | director | 40,000 0.0725% | $8.14 | $325,432 | -27.67% | ||
| 2022-12-20 | George Simeon | director | 40,000 0.0725% | $8.14 | $325,432 | -27.67% | ||
| 2022-12-20 | Siffert Joao MD | President and CEO | 6,300 0.0118% | $8.38 | $52,763 | -27.67% | ||
| 2022-12-19 | SR One Capital Fund I Aggregator LP | director | 360,000 0.6698% | $8.63 | $3.11M | -29.29% | ||
| 2022-12-19 | George Simeon | director | 360,000 0.6698% | $8.63 | $3.11M | -29.29% | ||
| 2022-12-19 | Siffert Joao MD | President and CEO | 1,150 0.0021% | $8.47 | $9,741 | -29.29% | ||
| 2022-12-16 | SR One Capital Fund I Aggregator LP | director | 500,000 0.8485% | $8.28 | $4.14M | -32.02% | ||
| 2022-12-16 | George Simeon | director | 500,000 0.8485% | $8.28 | $4.14M | -32.02% | ||
| 2022-12-09 | LAPPE RODNEY W | director | 15,000 0.0273% | $7.96 | $119,426 | -21.76% | ||
| 2022-03-21 | William Arsani | 25,000 0.0461% | $18.99 | $474,680 | -22.95% | |||
| 2022-03-18 | Sale | Xu Stella | 13,200 0.0246% | $20.34 | $268,488 | -26.91% |
Insider Historical Profitability
| Schmid John P. | director | 26965 0.0475% | $132,937.45 | 2 | 0 | |
| Prasad Deepa | director | 20000 0.0352% | $98,600.00 | 1 | 1 | +19.26% |
| Berger Heather A. | director | 1300 0.0023% | $6,409.00 | 1 | 0 | |
| William Arsani | director | 0 0% | $0 | 5 | 1 | <0.0001% |
| George Simeon | director | 6526476 11.4978% | $32.18M | 4 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$99,438,720 | 81 | 6.74% | $303.29M | |
$69,130,029 | 69 | 25.63% | $244.26M | |
$11,468,215 | 44 | 17.78% | $256.14M | |
$17,983,739 | 41 | 102.87% | $269.42M | |
$18,554,304 | 31 | -11.72% | $243.75M |
DSGN Institutional Investors: Active Positions
| Increased Positions | 51 | +49.51% | 3M | +10.84% |
| Decreased Positions | 40 | -38.83% | 2M | -6.19% |
| New Positions | 17 | New | 2M | New |
| Sold Out Positions | 19 | Sold Out | 798,905 | Sold Out |
| Total Postitions | 114 | +10.68% | 33M | +4.65% |
DSGN Ownership Change vs Market
Institutional Investor Ownership
| Sr One Capital Management, Lp | $30,707.00 | 11.45% | 6.53M | 0 | 0% | 2024-12-31 |
| Logos Global Management Lp | $19,844.00 | 7.4% | 4.22M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $12,137.00 | 4.53% | 2.58M | +220,802 | +9.36% | 2024-12-31 |
| Frazier Life Sciences Management, L.P. | $9,191.00 | 3.43% | 1.95M | +61,000 | +3.22% | 2024-12-31 |
| Point72 Asset Management, L.P. | $8,736.00 | 3.26% | 1.86M | +256,010 | +15.99% | 2024-12-31 |
| Baker Bros. Advisors Lp | $8,204.00 | 3.06% | 1.74M | 0 | 0% | 2024-12-31 |
| Tang Capital Management Llc | $6,968.00 | 2.6% | 1.48M | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $6,732.00 | 2.51% | 1.43M | +36,721 | +2.63% | 2024-12-31 |
| Almitas Capital Llc | $6,228.00 | 2.32% | 1.32M | 0 | 0% | 2024-12-31 |
| Citadel Advisors Llc | $4,511.00 | 1.68% | 958,793 | +383,243 | +66.59% | 2024-12-31 |